Background: In the context of Covid-19 infections, acute Olfactory Dysfunction (OD) is defined as decreased or altered sense of smell of duration of 14 days or less, in the absence of chronic rhinosinusitis, a history of head trauma, or neurotoxic medications. OD can be associated with flavor (smell+taste) dysfunction. However, Covid-19 may also affect real taste (sweet, salty, bitter, acidic, umami). OD is estimated to afflict 3%-20% of the population. Post-viral anosmia accounts for up to 40% of cases of anosmia or coronaviruses are thought to account for 10%-15% of these cases. As such, it is plausible that Covid-19 may cause OD. Aim: This work aims to determine the prevalence of olfactory dysfunction in coronavirus disease 2019 (Covid-19) patients. Materials & Methods: A systematic search was performed over different medical databases to identify sss studies, which studied the prevalence of olfactory dysfunction in Covid-19 patients. We conducted a meta-analysis process on the pooled prevalence of olfactory dysfunction as a primary main outcome. Results: Twelve studies were identified involving 16866 Covid-19 patients. Our meta-analysis process showed a pooled prevalence of olfactory dysfunction in Covid-19 patients=42.7% (95% CI=28.83 to 57.24) (p<0.001). Conclusion: To conclude, olfactory dysfunction is common in Covid-19 and maybe the only symptom. Coronavirus disease 2019-related OD can be severe and prolonged. Mucosal infiltration by CD68+ macrophages expressing SARS-CoV-2 viral antigen may contribute to Covid-19-related OD.
Select your language of interest to view the total content in your interested language
Annals of Medical and Health Sciences Research received 24805 citations as per google scholar report
The Annals of Medical and Health Sciences Research is a monthly multidisciplinary medical journal.